Statistical analysis plan for a pragmatic randomised controlled trial comparing enhanced acceptance and commitment therapy plus ( +) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial

actpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This paper outlines the statistical analysis plan and economic evaluation for the SURECAN trial, a pragmatic randomized controlled study comparing enhanced Acceptance and Commitment Therapy (ACT+) to usual aftercare for cancer survivors with poor quality of life. It details the methodology for assessing effectiveness and cost-effectiveness at 52 weeks post-randomization, including primary outcomes measured by the FACT-G scale and secondary measures such as fear of recurrence and fatigue. The resource is intended for researchers or clinicians interested in the methodological framework of this specific clinical trial.

ID
0a286932cc114fd5
Source org
PubMed Central
Author
Clare Robinson (Queen Mary University of London), Trudie Chalder (King's College London), Paul McCrone (University of Greenwich), Olivier Quintin (Queen Mary University of London), Evdoxia Gkaintatzi (University of Greenwich), Imran Khan (Queen Mary University of London), Stephanie Taylor (Queen Mary University of London), on behalf of the SURECAN GROUP
Published
2025-01-30
OA status
gold
DOI
10.1186/s13063-025-08734-9
PMID
Not recorded
PMCID
Not recorded
Citations
2

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:0a286932cc114fd5,
  title = {Statistical analysis plan for a pragmatic randomised controlled trial comparing enhanced acceptance and commitment therapy plus ( +) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial},
  author = {Clare Robinson and Trudie Chalder and Paul McCrone and Olivier Quintin and Evdoxia Gkaintatzi and Imran Khan and Stephanie Taylor and on behalf of the SURECAN GROUP},
  year = {2025},
  journal = {PubMed Central},
  doi = {10.1186/s13063-025-08734-9},
  url = {https://doi.org/10.1186/s13063-025-08734-9}
}

RIS

TY  - JOUR
TI  - Statistical analysis plan for a pragmatic randomised controlled trial comparing enhanced acceptance and commitment therapy plus ( +) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial
AU  - Robinson, Clare
AU  - Chalder, Trudie
AU  - McCrone, Paul
AU  - Quintin, Olivier
AU  - Gkaintatzi, Evdoxia
AU  - Khan, Imran
AU  - Taylor, Stephanie
AU  - GROUP, on behalf of the SURECAN
PY  - 2025
PB  - PubMed Central
DO  - 10.1186/s13063-025-08734-9
UR  - https://doi.org/10.1186/s13063-025-08734-9
ER  -

APA

Robinson, C., Chalder, T., McCrone, P., Quintin, O., Gkaintatzi, E., Khan, I., Taylor, S., & GROUP, O. B. O. T. S. (2025). Statistical analysis plan for a pragmatic randomised controlled trial comparing enhanced acceptance and commitment therapy plus ( +) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial. PubMed Central. https://doi.org/10.1186/s13063-025-08734-9

Related entries

More like this